These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27214396)

  • 21. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
    Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
    J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cascade screening program for familial hypercholesterolemia.
    Rubio-Marín P; Michán-Doña A; Maraver-Delgado J; Arroyo-Olivares R; Barrado Varea R; Pérez de Isla L; Mata P
    Endocrinol Diabetes Nutr (Engl Ed); 2018 May; 65(5):280-286. PubMed ID: 29523491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
    Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
    Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between the Presence of Carotid Artery Plaque and Cardiovascular Events in Patients With Genetic Hypercholesterolemia.
    Bea AM; Civeira F; Jarauta E; Lamiquiz-Moneo I; Pérez-Calahorra S; Marco-Benedí V; Cenarro A; Mateo-Gallego R
    Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):551-558. PubMed ID: 28215923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
    Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
    Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia.
    Paquette M; Bernard S; Ruel I; Blank DW; Genest J; Baass A
    J Clin Lipidol; 2019; 13(1):123-128. PubMed ID: 30318454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cascade genetic screening for familial hypercholesterolemia.
    Leren TP
    Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia.
    Paquette M; Dufour R; Baass A
    J Clin Lipidol; 2017; 11(1):80-86. PubMed ID: 28391914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. My Approach to the Patient With Familial Hypercholesterolemia.
    Safarova MS; Kullo IJ
    Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cascade screening for familial hypercholesterolemia should be organized at a national level.
    Leren TP; Bogsrud MP
    Curr Opin Lipidol; 2022 Aug; 33(4):231-236. PubMed ID: 35942821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemoglobin concentration, hematocrit and red blood cell count predict major adverse cardiovascular events in patients with familial hypercholesterolemia.
    Paquette M; Bernard S; Baass A
    Atherosclerosis; 2021 Oct; 335():41-46. PubMed ID: 34547589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.
    Ogura M; Hori M; Harada-Shiba M
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.
    Fuentes F; Alcala-Diaz JF; Watts GF; Alonso R; Muñiz O; Díaz-Díaz JL; Mata N; Sanchez Muñoz-Torrero JF; Brea Á; Galiana J; Figueras R; Aguado R; Piedecausa M; Cepeda JM; Vidal JI; Rodríguez-Cantalejo F; López-Miranda J; Mata P;
    Int J Cardiol; 2015 Dec; 201():79-84. PubMed ID: 26296047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia.
    Paquette M; Chong M; Thériault S; Dufour R; Paré G; Baass A
    J Clin Lipidol; 2017; 11(3):725-732.e5. PubMed ID: 28456682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cascade genetic testing of familial hypercholesterolemia A new opportunity for prevention].
    Butty A; Von Känel T; Gallino A; Beer JH; Nanchen D
    Rev Med Suisse; 2022 Mar; 18(772):438-443. PubMed ID: 35266344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evaluation of cascade testing for familial hypercholesterolemia.
    Morris JK; Wald DS; Wald NJ
    Am J Med Genet A; 2012 Jan; 158A(1):78-84. PubMed ID: 22139944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives from individuals with familial hypercholesterolemia on direct contact in cascade screening.
    Schwiter R; Brown E; Murray B; Kindt I; Van Enkevort E; Pollin TI; Sturm AC
    J Genet Couns; 2020 Dec; 29(6):1142-1150. PubMed ID: 32223038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.